A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: Preliminary results

Trials

Volumn 12, Issue , 2011, Pages

  Krauss Silva, Leticia ^a   Moreira, Maria Elizabeth L ^a   Alves, Mariane B ^a,b   Braga, Alcione ^c   Camacho, Karla G ^a   Batista, Maria Rosa R ^a   Almada Horta, Antonio ^b   Rebello, Maria R ^a   Guerra, Fernando ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c PROCEP   (Brazil)

Author keywords

History of preterm delivery; Prevention; Probiotics; Randomised controlled parallel group trial; Spontaneous preterm delivery

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOODY DIARRHEA; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEADACHE; HEALTH PRACTITIONER; HEARTBURN; HUMAN; LACTOBACILLUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; LEUKOMALACIA; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; NAUSEA; NAUSEA AND VOMITING; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN SEPSIS; OUTCOME ASSESSMENT; PREGNANCY; PREGNANT WOMAN; PRELIMINARY COMMUNICATION; PREMATURE LABOR; PREMATURITY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME; RETINOPATHY; SIDE EFFECT; SOMNOLENCE; STOMACH PAIN; SYNCOPE; TACHYCARDIA; UTERUS CONTRACTION; VAGINITIS; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; NEWBORN;

FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREMATURE BIRTH; PROBIOTICS; VAGINOSIS, BACTERIAL;

EID: 80455174401     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-239     Document Type: Article

References (51)

1. Agency for Healthcare Research and Quality Management of preterm labor. Evidence report/technology assessment n. 18, AHRQ public n. 01-E021 2000, Agency for Healthcare Research and Quality.
2. Leal MC, Gama SGN, Campos MR. Fatores associados à morbi-mortalidade perinatal em uma amostra de maternidades públicas e privadas do município do Rio de Janeiro, 1999-2001. Cadernos de Saúde Pública 2004, 20(Supl 1):S20-S33.
3. Campos MR, Leal MC, Souza PR, Cunha CB. Consistência entre fontes de dados e confiabilidade inter-observador do estudo da morbi-mortalidade e atenção peri e neonatal no município do Rio de Janeiro. Cadernos de Saúde Pública 2004, 20(Supl 1):S34-S43.
4. Berkowitz GS, Prince CB, Lapinski RH. Risk factors for preterm birth subtypes. Epidemiology 1998, 9(3):279-285. 10.1097/00001648-199805000-00011, 9583419.
5. Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutrition Reviews 2002, 60(5):S19-S25. 10.1301/00296640260130696, 12035853.
6. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infections and prematurity and the role of preventive strategies. Semin Neonatol 2002, 7:259-274.
7. Goldenberg RL, Iams JD, Mercer BM, Meis P, Moawad A, Das A, Copper R, Johnson F, . for the national Institute of Child Health and Human Development Network What we have learned about the predictors of preterm birth. Seminars in Perinatology 2003, 27(3):185-93. 10.1016/S0146-0005(03)00017-X, 12889585, for the national Institute of Child Health and Human Development Network.
8. Mercer BM, Goldenberg RL, Das A. The preterm prediction study: A clinical risk assessment system. Am J Obstet Gynecol 1996, 174(6):1885-1895. 10.1016/S0002-9378(96)70225-9, 8678155.
9. Klebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, Iams JD, Moawad A, Miodovnik M, Sibai BM, van Dorsten JP, Dombrowski MP, . for the National Institute for Child Health and Development Maternal Fetal Medicine Units Network Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. American Journal of Obstetrics and Gynecology 2004, 190(2):363-70. 10.1016/j.ajog.2003.08.020, 14981375, for the National Institute for Child Health and Development Maternal Fetal Medicine Units Network.
10. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Jun JK. The relationships among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000, 183(5):1124-9. 10.1067/mob.2000.109035, 11084553.
11. Yoon BH, Romero R, Kim KS. Transactions of the nineteenth annual meeting of the society for maternal-fetal medicine. Am J Obstet Gynecol 1999, 181(4):773-9. 10.1016/S0002-9378(99)70299-1, 10521727.
12. Yoon BH, Romero R, Yang SH. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174(5):1433-40. 10.1016/S0002-9378(96)70585-9, 9065108.
13. Gomez R, Romero R, Ghezzi F. The Fetal Inflammatory Response Syndrome. Am J Obstet Gynecol 1998, 179(1):194-202. 10.1016/S0002-9378(98)70272-8, 9704787.
14. Cauci S. Vaginal Immunity in Bacterial Vaginosis. Current Infectious Disease Reports 2004, 6(6):450-6. 10.1007/s11908-004-0064-8, 15538982.
15. McGregor J, French JI, Richter R. Cervicovaginal microflora and pregnancy outcome: results of double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol 1990, 163(5 Pt 1):1580-91.
16. Hauth JC, Goldenberg RL, Andrews WW. Reduced Incidence of Preterm Delivery With Metronidazole and Erythromycin in Women with Bacterial Vaginosis. N Engl J Med 1995, 333(26):1732-6. 10.1056/NEJM199512283332603, 7491136.
17. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, Miodovnik M, Dombrowski M, O'Sullivan MJ, van Dorsten JP, Langer O, Roberts J. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal and Fetal Medicine Units. N Engl J Med 2000, 343(8):534-40.
18. Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, Leveno KJ, Wapmer R, Moawad A, O'Sullivan MJ, Caritis SN, Iams JD, Langer O, Miodovnik M, Dombrowski M, . for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003, 101(5):847-55. 10.1016/S0029-7844(03)00172-8, 12738139, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.
19. Simhan HN, Caritis SN, Krohn MA, Tejada BM, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003, 189(2):560-7. 10.1067/S0002-9378(03)00518-0, 14520234.
20. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial Vaginosis. The inflammatory response and the preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004, 190(6):1509-19. 10.1016/j.ajog.2004.01.002, 15284723.
21. Klein LL, Gibbs R. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol 2004, 190:1493-502. 10.1016/j.ajog.2004.03.014, 15284720.
22. Isolauri E, Salminen S, Ouwehand AC. Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol 2004, 18(2):299-313. 10.1016/j.bpg.2003.10.006, 15123071.
23. Vrese M, Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br J Nutr 2002, 88(Suppl 1):S59-S66.
24. Reid G, Devillard E. Probiotics for mother and child. J Clin Gastroenterol 2004, 38(Suppl 2):S94-S101.
25. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003, 189(4):1202-8. 10.1067/S0002-9378(03)00495-2, 14586379.
26. Reid G, Charbonneau D, Erb J, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbio 2003, 35:131-4.
27. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbio 2001, 32:37-41.
28. Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2001, 183(Suppl 1):S77-80.
29. Reid G, Bruce AW, Fraser N. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbio 2001, 30:49-52.
30. Shalev E. Ingestion of probiotics: Optional treatment of bacterial vaginosis in pregnancy. IMAJ 2002, 4:357-60.
31. Krauss-Silva, et al. Reproductive Health 2010, 7:14. 10.1186/1742-4755-7-14, 2911410, 20591191., http://www.reproductive-health-journal.com/content/7/1/14
32. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiology 1991, 29(2):297-301.
33. Vermont Oxford Network. Database Manual of Operations. >Release 5.0.Burlington, VT 2000,
34. Altman DG, Schulz KF, Moher D, Egger M, et al. The Revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134:663-694.
35. Moher D, Hopewell S, Schulz KF, Montori V, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomized trials. BMJ 2010, 340.
36. Schulz KF, Altman DG, Moher D, . for the CONSORT Group CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. Trials 2010, 11:32. 10.1186/1745-6215-11-32, 2857832, 20334632, for the CONSORT Group.
37. Meis PJ, Goldenberg RL, Mercer B, et al. The Preterm Prediction Study: significance of vaginal infections. Am J Obst Gynecol 1995, 173:1231-5.
38. Hauth JC, Macpherson C, Carey JC, Klebanoff MA, Hillier SL, Ernest JM, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, . for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network Early pregnancy threshold vagina pH and gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol 2003, 188(3):831-5. 10.1067/mob.2003.184, 12634666, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.
39. Simhan HN, Caritis NS, Krohn MA, Hillier SL. Elevated Vaginal pH And Neutrophils Are Associated Strongly with Early Spontaneous Preterm Birth. Am J Obstet Gynecol 2003, 189(4):1150-4. 10.1067/S0002-9378(03)00582-9, 14586369.
40. Monga M, Blanco J. Intrauterine Infection and Preterm Labor. Inf Dis Obstet Gynecol 1995, 3:37-44.
41. Mercer BM. Preterm Premature Rupture of Membranes. Obstet Gynecol 2003, 101:178-193. 10.1016/S0029-7844(02)02366-9, 12517665.
42. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet and Gynecol 1998, 179(10):186-93.
43. Goldenberg R, Culhane JF, Iams J, Romero R. Epidemiology and causes of preterm birth. The Lancet 2008, 371:75-84.
44. Cloherty JP, Eichenwald EC, Stark AR. Manual of Neonatal Care. 2004, Lippincott Williams & Wilkins; Fifth edition, Philadelphia.
45. Pahlson C, Larsson PG. The ecologically wrong vaginal lactobacilli. Medical Hypotheses 1991, 36:126-130. 10.1016/0306-9877(91)90253-U, 1779915.
46. Famularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses 2001, 56(4):421-30. 10.1054/mehy.2000.1195, 11339841.
47. McLean NW, Rosenstein IJ. Characterization and selection of a Lactobacillus species to recolonize the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000, 49:543-52.
48. Iams JD, Goldenberg RL, Mercer BM, Moawad A, Das AF, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, Dombrowski M, Roberts J, . for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network The Preterm Prediction Study: Can low-risk women destined for spontaneous preterm birth be identified?. Am J Obstet Gynecol 2001, 184(4):652-655. 10.1067/mob.2001.111248, 11262467, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.
49. Genc MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, Norwitz ER, Onderdonk AB. A disproportionate increase in IL-1B over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstetrics Gynecology 2004, 190(5):1191-1197.
50. Kalinka J, Sobala W, Wasiela M, Brzezinska-Błaszczyk E. Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery. AJRI 2005, 54:70-76.
51. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002, 110(4):617-23. 10.1067/mai.2002.128528, 12373271.